|
[1]
|
Ghofrani, H., Gomberg-Maitland, M., Zhao, L. and Grimminger, F. (2025) Mechanisms and Treatment of Pulmonary Arterial Hypertension. Nature Reviews Cardiology, 22, 105-120. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Latimer, K., Layne, M. and Payne, M. (2024) Pulmonary Hypertension. American Family Physician, 110, 183-191.
|
|
[3]
|
GBD 2021 Stroke Risk Factor Collaborators (2024) Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021. The Lancet Neurology, 23, 973-1003.
|
|
[4]
|
GBD 2021 Pulmonary Arterial Hypertension Collaborators (2025) Global, Regional, and National Burden of Pulmonary Arterial Hypertension, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021. The Lancet Respiratory Medicine, 13, 69-79.
|
|
[5]
|
SEC Working Group for the 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension and SEC Guidelines Committee (2023) Comments on the 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. Revista Española de Cardiología (English Edition), 76, 294-300.
|
|
[6]
|
Cao, Y., Yao, W., Yang, T., Yang, M., Liu, Z., Luo, H., et al. (2024) Elucidating the Mechanisms of Buyang Huanwu Decoction in Treating Chronic Cerebral Ischemia: A Combined Approach Using Network Pharmacology, Molecular Docking, and in Vivo Validation. Phytomedicine, 132, Article ID: 155820. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Mo, J., Liao, W., Du, J., Huang, X., Li, Y., Su, A., et al. (2024) Buyang Huanwu Decoction Improves Synaptic Plasticity of Ischemic Stroke by Regulating the cAMP/PKA/CREB Pathway. Journal of Ethnopharmacology, 335, Article ID: 118636. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Huang, H., Liu, S., Wu, J., Zhu, J., Xu, J., Yu, S., et al. (2025) Buyang Huanwu Decoction Alleviates Ischemic Stroke Injury by Inhibiting Ferroptosis via the Nrf2/gpx4 Pathway. Drug Design, Development and Therapy, 19, 2285-2305. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Colon Hidalgo, D., Elajaili, H., Suliman, H., George, M.P., Delaney, C. and Nozik, E. (2022) Metabolism, Mitochondrial Dysfunction, and Redox Homeostasis in Pulmonary Hypertension. Antioxidants, 11, Article No. 428. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Zhang, W., Liu, B., Wang, Y., Zhang, H., He, L., Wang, P., et al. (2022) Mitochondrial Dysfunction in Pulmonary Arterial Hypertension. Frontiers in Physiology, 13, Article ID: 1079989. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
D’Alessandro, A., El Kasmi, K.C., Plecitá-Hlavatá, L., Ježek, P., Li, M., Zhang, H., et al. (2018) Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming. Antioxidants & Redox Signaling, 28, 230-250. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Riou, M., Enache, I., Sauer, F., Charles, A. and Geny, B. (2023) Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches? International Journal of Molecular Sciences, 24, Article No. 9572. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Geng, Y., Hu, Y., Zhang, F., Tuo, Y., Ge, R. and Bai, Z. (2023) Mitochondria in Hypoxic Pulmonary Hypertension, Roles and the Potential Targets. Frontiers in Physiology, 14, Article ID: 1239643. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Culley, M.K. and Chan, S.Y. (2018) Mitochondrial Metabolism in Pulmonary Hypertension: Beyond Mountains There Are Mountains. Journal of Clinical Investigation, 128, 3704-3715. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Deng, X., Qiu, P., Li, X., Hu, Y., Que, Q., Zhang, K., et al. (2025) Potential of Sivelestat for Pulmonary Arterial Hypertension Treatment: Network Pharmacology-Based Target Identification and Mechanistic Exploration. Drug Design, Development and Therapy, 19, 4123-4138. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wu, P., Xie, X., Chen, M., Sun, J., Cai, L., Wei, J., et al. (2021) Elucidation of the Mechanisms and Molecular Targets of Qishen Yiqi Formula for the Treatment of Pulmonary Arterial Hypertension Using a Bioinformatics/Network Topology-Based Strategy. Combinatorial Chemistry & High Throughput Screening, 24, 701-715. [Google Scholar] [CrossRef] [PubMed]
|